Difficulty: Medium
Average Score: 85%
Practice
Indicate the following neuromuscular blocker, which would be contraindicated in patients with renal failure:
Correct answer
A
Rationale
In the context of Lifespan Pharmacology, understanding the effects of neuromuscular blockers in patients with renal failure is crucial due to the potential impact on drug metabolism and elimination.
The correct answer is A) Pipecuronium. Pipecuronium is primarily eliminated through the kidneys, and in patients with renal failure, its clearance is significantly reduced. This can lead to drug accumulation, prolonged effects, and increased risk of toxicity, making it contraindicated in this patient population.
Option B) Succinylcholine is metabolized by plasma pseudocholinesterase and does not rely on renal clearance, so it is not contraindicated in renal failure.
Option C) Atracurium and Option D) Rapacuronium are also metabolized independently of renal function, therefore they are not contraindicated in patients with renal failure.
It is essential for healthcare professionals to be aware of the pharmacokinetic profiles of drugs, especially in vulnerable populations like those with renal impairment, to ensure safe and effective pharmacological management. Understanding contraindications based on renal function can prevent adverse drug reactions and optimize patient care.
The correct answer is A) Pipecuronium. Pipecuronium is primarily eliminated through the kidneys, and in patients with renal failure, its clearance is significantly reduced. This can lead to drug accumulation, prolonged effects, and increased risk of toxicity, making it contraindicated in this patient population.
Option B) Succinylcholine is metabolized by plasma pseudocholinesterase and does not rely on renal clearance, so it is not contraindicated in renal failure.
Option C) Atracurium and Option D) Rapacuronium are also metabolized independently of renal function, therefore they are not contraindicated in patients with renal failure.
It is essential for healthcare professionals to be aware of the pharmacokinetic profiles of drugs, especially in vulnerable populations like those with renal impairment, to ensure safe and effective pharmacological management. Understanding contraindications based on renal function can prevent adverse drug reactions and optimize patient care.